Investing in vaccines for developing countries: How public-private partnerships can confront neglected diseases

Human Vaccines

Volumn 5, Issue 6, 2009, Pages 368-369

  Yaïch, Mansour ^a  

^a PATH   (United States)

Author keywords

Advance Market Commitment; Japanese encephalitis; Public private partnership; SA 14 14 2; Vaccine manufacturers

Indexed keywords

VACCINE;

CONFERENCE PAPER; DEVELOPING COUNTRY; DRUG COST; DRUG INDUSTRY; DRUG MARKETING; DRUG QUALITY; DRUG USE; HEALTH CARE ACCESS; HEALTH CARE AVAILABILITY; HEALTH CARE DISTRIBUTION; HEALTH CARE MANAGEMENT; HEALTH CARE PLANNING; IMMUNIZATION; INVESTMENT; PREVENTIVE HEALTH SERVICE; PROPHYLAXIS; VACCINE PRODUCTION;

EID: 70349547097     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.5.6.8172     Document Type: Conference Paper

References (4)

1. GAVI Alliance, The World Bank. Advance Market Commitment for vaccines website. 2007. Available at: www.vaccineamc.org. Accessed 2009.
2. World Health Organization. Vector-borne viral infections: Japanese encephalitis. World Health Organization; 2009. Available at: www.who.int/ vaccine_research/diseases/vector/en/index1.html. Accessed 2009.
3. World Health Organization. Japanese encephalitis vaccines. Weekly Epidemiological Record 2006; 81:331-40.
4. World Health Organization. Report on the Third Biregional Meeting on Control of Japanese Encephalitis, April 26, 2007; Manila. Manila: World Health Organization Regional Office for the Western Pacific 2007.